Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Classement en actions #33269
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Prix de l'action
$5.47
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.99M
Changement (1 jour)
6.21%
Changement (1 an)
7.47%
Pays
US
Échange CNS Pharmaceuticals, Inc. (CNSP)

Catégorie

Le prix CNSP avec la capitalisation boursière de B
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
CNSP
$5.47
Capitalisation boursière de CNS Pharmaceuticals, Inc.(CNSP)
Capitalisation boursière: $7.99M
En August 2026, CNS Pharmaceuticals, Inc. a une capitalisation boursière de $7.99M. Cela fait de CNS Pharmaceuticals, Inc. la 33269th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de CNS Pharmaceuticals, Inc. du 2019 au 2026
CNSP par rapport au top 5 des plus populaires stocks
Prix pour CNSP L’actif B La capitalisation boursière de B Résultats
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,730,311 $7.99M
$5.452T +68,195,709.39%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$3,072,189 $7.99M
$4.490T +56,164,241.21%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,848,028 $7.99M
$4.162T +52,066,224.70%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$2,515,450 $7.99M
$3.676T +45,986,185.89%
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.
$1,938,442 $7.99M
$2.833T +35,437,596.65%